Fig. 3From: Drug delivery nanocarriers and recent advances ventured to improve therapeutic efficacy against osteosarcoma: an overviewOS targeting by antibody-drug conjugates wherein the cytotoxic agents and other therapeutics are linked to antibody designed against specific cell target (OS) [72]Back to article page